Reply to 'Promotion of sleep by targeting the orexin system in rats, dogs and humans' [2]

Nature Medicine

Volumn 13, Issue 5, 2007, Pages 526-

  Jenck, Francois ^a   Brisbare Roch, Catherine ^a   Scherz, Michael ^a   Flores, Susan ^a   Koberstein, Ralf ^a   Nayler, Oliver ^a   Dingemanse, Jasper ^a   Clozel, Martine ^a  

^a ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACT 078573; OREXIN 1 RECEPTOR; OREXIN 1 RECEPTOR ANTAGONIST; OREXIN 2 RECEPTOR; OREXIN 2 RECEPTOR ANTAGONIST; OREXIN A; OREXIN B; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; ZOLPIDEM;

CATAPLEXY; CLINICAL TRIAL; ELECTROENCEPHALOGRAM; HUMAN; INSOMNIA; LETTER; NARCOLEPSY; NONHUMAN; NONREM SLEEP; OREXIN DEFICIENCY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECEPTOR BLOCKING; REM SLEEP DEPRIVATION; SOMNOLENCE;

CANIS FAMILIARIS; RATTUS;

EID: 34249745173     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0507-526     Document Type: Letter

References (7)

1. Brisbare-Roch, C. et al. Nat. Med. 13, 150-155 (2007).
2. Oka, Y. et al. Sleep 29, 1439-1443 (2006).
3. Dauvilliers, Y., Arnulf, I. & Mignot, E. Lancet 369, 499-511 (2007).
4. Crocker, A. et al. Neurology 65, 1184-1188 (2005).
5. Blouin, A.M. et al. Neurology 65, 1189-1192 (2005).
6. Siegel, J.M. & Boehmer, L.N. Nat. Clin. Pract. Neurol. 2, 548-556 (2006).
7. Nykamp, K. et al. Clin. Neurophysiol. 110, 1531-1534 (1999).